
Vimta Labs Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Vimta Labs analyst target 2027: Rs 560 (-2%). 2028: Rs 635. Long-term target 2030: Rs 825 (+44%). CMP Rs 572.75.
Updated: 14 Aug 2026 • 4:06 pm
Posted by:

Quick Answer
The Vimta Labs share price target for 2027 is Rs 560, which sits approximately below the current price of Rs 572.75. Analysts expect a stronger recovery from 2028, with the target rising to Rs 635 before reaching Rs 825 by 2030 , a potential gain of approximately 44 percent from today's levels. FY26 EPS of ₹17.5 growing approximately14% a year, capitalised at approximately28x forward earnings; growth tapers to ap. Investors considering Vimta Labs should weigh the 2030 upside case against the near-term consolidation phase and the sector-specific risks outlined below.
Vimta Labs is trading at Rs 572.75 with near-term consolidation expected , the 2027 target of Rs 560 is approximately 2 percent below the current price. The more compelling case is in the outer years , Rs 635 by 2028 and Rs 825 by 2030 , as the earnings model builds toward that trajectory. FY26 EPS of ₹17.5 growing approximately14% a year, capitalised at approximately28x forward earnings; growth tapers to approximately11% further out.
This article breaks down the Vimta Labs share price target for 2027, 2028, and 2030, the sector-specific drivers behind the analyst model, and the risks that could delay or derail the forecast.
Click Here – Get Free Investment Predictions
Vimta Labs Company Overview and Share Price Target Summary
| Metric | Details |
|---|---|
| NSE Ticker | VIMTALABS |
| Sector | Diversified |
| CMP (14 Aug 2026) | Rs 572.75 |
| Market Cap | Rs 2488 Cr |
| Vimta Labs Share Price Target 2027 | Rs 560 (-2%) |
| Vimta Labs Share Price Target 2028 | Rs 635 (+11%) |
| Vimta Labs Share Price Target 2030 | Rs 825 (+44%) |
| Bull Case 2030 | Rs 1,056 |
| Bear Case 2030 | Rs 619 |
What most investors miss about Vimta Labs: Near debt-free (D/E 0.02); ROCE 17.6% notably higher than ROE, suggesting efficient capital use
FY26 EPS of ₹17.5 growing approximately14% a year, capitalised at approximately28x forward earnings; growth tapers to approximately11% further out..
Why Analysts Have Set the Vimta Labs share price target at Rs 560 for 2027
Core Revenue Growth Is Outpacing Sector Benchmarks
This is the clearest reason the analyst model converges on Rs 825 by 2030. FY26 EPS of ₹17.5 growing approximately14% a year, capitalised at approximately28x forward earnings; growth tapers to ap. Tracking this factor quarterly gives the earliest signal on whether the long-term analyst target stays on course.
Margin Improvement Is Translating Into Earnings Quality
The Vimta Labs share price target for 2028 , Rs 635 , is built partly on this continuing to hold. If it deteriorates, the timeline for the outer-year forecast extends, not the target itself. Investors should track it with every results cycle.
Balance Sheet Strength Supports Sustained Growth Investment
This underpins Vimta Labs's growth beyond the 2027 near-term. It is the kind of durable structural factor that keeps analysts positive on the 2030 target even when quarterly numbers disappoint.
Management Has a Track Record of Executing Through Cycles
For the 2028 recovery thesis to work, Vimta Labs needs to maintain consistency here. One cycle of weakness would not break the long-term case, but two consecutive quarters of deterioration would prompt downgrades.
India's Broader Economic Growth Creates a Structural Tailwind
This is the macro layer that most company-specific screens miss. It amplifies Vimta Labs's own earnings compounding and is why analysts are more constructive on the 2030 horizon than on 2027.
Vimta Labs Share Price Target 2027, 2028 and 2030: Year-Wise Breakdown
2027 Target: Rs 560
Rs 560 is the 2027 analyst target, implying near-term consolidation expected , the 2027 target of Rs 560 is approximately 2 percent below the current price. At this level, Vimta Labs would be trading on forward multiples consistent with the current earnings trajectory. The 2027 milestone is essentially a staging post , confirmed only after two to three quarters of on-track delivery.
2028 Target: Rs 635
Rs 635 is where analysts see Vimta Labs by 2028, roughly 11 percent above today's price. By FY29, the business should have moved past the near-term consolidation, and the Vimta Labs share price target for 2028 typically re-rates faster than markets initially expect once the earnings inflection becomes visible.
2030 Target: Rs 825
The long-term case is Rs 825 by 2030 , a potential gain of approximately 44 percent from CMP Rs 572.75, which works out to a 4-year CAGR of roughly 10 percent. By FY31, Vimta Labs should be operating at a scale and earnings quality that justifies the multiple implied by this target. Please verify all data at NSE and BSE before making any investment decision.
Bull Case and Bear Case for Vimta Labs by 2030
Bull Case: Rs 1,056
The bull case lands at Rs 1,056 by 2030. This requires better-than-expected earnings growth alongside a re-rating of the multiple , both need to land together. Favourable macro conditions, new business wins, or a sector re-rating could drive this scenario without needing extraordinary operational delivery from the company.
Bear Case: Rs 619
The bear case is Rs 619 by 2030 , still above today's price in most scenarios, but a significantly slower path. This applies if earnings miss across FY27 to FY28, competitive pressure intensifies, or a macro slowdown compresses sector multiples before Vimta Labs can re-rate upward.
| Scenario | Target 2030 | Return | Key Assumption |
|---|---|---|---|
| Bull Case | Rs 1,056 | +84% | Above-consensus growth; multiple expansion |
| Base Case | Rs 825 | +44% | Base-case CAGR; peer multiples hold |
| Bear Case | Rs 619 | +8% | Earnings miss; macro pressure; multiple contraction |
Key Risks to the Vimta Labs Forecast
Earnings Deceleration
Any quarter where Vimta Labs's growth falls below expectations is likely to trigger a PE de-rating, not just an EPS miss, compounding the price impact.
Sector Headwinds
Policy changes, commodity cycles, or demand slowdowns specific to Vimta Labs's sector could reduce visibility on the targets beyond 12 months.
Competitive Disruption
New entrants or pricing aggression from existing competitors can erode the market share assumptions built into the analyst model.
Macro Risks
A broader economic slowdown affecting consumer or corporate spending would compress multiples across the board, regardless of company-specific delivery.
How to Invest in Vimta Labs
Start by tracking Vimta Labs's quarterly results against the model assumptions. The Univest Screener gives you live fundamentals, analyst upgrade history, and price alerts on NSE ticker VIMTALABS , the same data points that drive the Vimta Labs share price target model. Build positions in tranches across the 2027 to 2028 window rather than committing fully now, and consult a SEBI-registered financial advisor before investing.
Track This Stock Live on the Univest Screener
Conclusion
The Vimta Labs share price target of Rs 560 for 2027, Rs 635 for 2028, and Rs 825 for 2030 reflects the analyst model built on Vimta Labs's earnings trajectory in the diversified sector. The near-term picture is one of consolidation; the case for patient investors is in the 2028 to 2030 window. Always verify financial data at NSE India and BSE India before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Download the Univest iOS App or Univest Android App to track Vimta Labs share price live and get daily stock recommendations.
Frequently Asked Questions on Vimta Labs Share Price Target 2027 2028 and 2030
What is the Vimta Labs share price target for 2027?
Ans. The Vimta Labs share price target for 2027 is Rs 560, which is approximately 2 percent slightly below the current market price of Rs 572.75. This near-term target reflects the analyst consensus as of August 2026. Verify all data at NSE India before investing.
What is the Vimta Labs share price target for 2030?
Ans. The 2030 analyst target for Vimta Labs is Rs 825, implying approximately 44 percent potential upside from CMP Rs 572.75. This is the base-case extrapolation from the current earnings growth model. These are analyst estimates and not guaranteed returns.
What is the Vimta Labs share price target for 2028?
Ans. The Vimta Labs share price target for 2028 is Rs 635, approximately 11 percent from the current price. By FY29, the business should be past the near-term consolidation phase, which makes the 2028 target more realistically achievable than the 2027 level.
Is Vimta Labs a good long-term investment?
Ans. Vimta Labs has a defined earnings growth thesis in the diversified sector, with targets that project meaningful upside by 2030. Whether it suits your portfolio depends on your risk appetite, investment horizon, and current allocation. Speak with a SEBI-registered financial advisor before deciding.
What are the key risks to the Vimta Labs analyst forecast?
Ans. The most significant risks are earnings deceleration and sector headwinds. Beyond these, broader macro slowdowns and sector-specific headwinds can compress multiples even when the company itself is executing well.
What is the bull case for Vimta Labs by 2030?
Ans. The bull case target is Rs 1,056 by 2030. This requires above-consensus earnings growth and a re-rating of the PE multiple , both need to happen together. These are analyst projections, not guaranteed outcomes.
What sector does Vimta Labs belong to?
Ans. Vimta Labs operates in the diversified sector. This sector classification influences the peer multiples applied in the analyst target model and the macro factors that most directly affect the company's earnings outlook.
How can I track and invest in Vimta Labs?
Ans. You can buy Vimta Labs shares through any SEBI-registered broker using NSE ticker VIMTALABS. The Univest Screener lets you track live fundamentals, set price alerts, and monitor analyst ratings. Always consult a SEBI-registered financial advisor before investing.
Recent Articles

Sakthi Sugars Q1 FY27 Results: Revenue Grows 25% to Rs 376 Crore, Net Loss Persists at Rs 1 Crore
14 August 2026

Sudarshan Colorants India Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
14 August 2026

SRM Contractors Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
14 August 2026

Subros Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
14 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sakthi Sugars Q1 FY27 Results: Revenue Grows 25% to Rs 376 Crore, Net Loss Persists at Rs 1 Crore
Sudarshan Colorants India Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
SRM Contractors Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Subros Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
Sunteck Realty Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





